Why Choose EverydayMeds for Your Complete Dose Journey?
Complete Mounjaro and Wegovy Doses: Your Entire Treatment Journey
When comparing Mounjaro and Wegovy doses, the most crucial factor is ensuring consistent supply throughout your treatment journey. EverydayMeds stocks every single dose strength of both medications, eliminating the frustration of switching pharmacies mid-treatment. Our comprehensive inventory includes all five Wegovy doses (0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg) alongside the complete Mounjaro dose range, ensuring seamless progression from your initial starter dose through to long-term maintenance therapy.
Both Mounjaro and Wegovy doses follow identical escalation schedules over 17 weeks, but the underlying mechanisms differ significantly. Wegovy contains semaglutide, a GLP-1 receptor agonist, while Mounjaro uses tirzepatide, which targets both GIP and GLP-1 receptors. This dual-action approach of Mounjaro may offer different therapeutic benefits compared to Wegovy's single-pathway mechanism, though both are designed to support weight management alongside a reduced-calorie diet and increased physical activity. Your prescriber can evaluate which medication and dosing schedule aligns best with your medical history and treatment goals.
Wegovy and Mounjaro Doses: Transparent Pricing Structure
Understanding the cost implications of Mounjaro and Wegovy doses helps you plan your weight management investment effectively. Our Wegovy pricing begins at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. New customers benefit from discount code FIRST40, while returning customers use DOSE25, both applied automatically at checkout to reach these final prices.
For enhanced convenience, our bundle options provide Reliable Supply continuity. The Intro Trio bundle (0.25mg, 0.5mg, and 1mg) costs £299.99, covering your first 12 weeks of treatment, while the Ultimate Stability Trio delivers three months of 2.4mg maintenance therapy for £649.99. These bundles ensure uninterrupted treatment progression without the need to place multiple orders, particularly valuable given the structured nature of Mounjaro and Wegovy dose escalation protocols.
Clinical Evidence Supporting Mounjaro and Wegovy Doses
The effectiveness of both Mounjaro and Wegovy doses has been demonstrated through extensive clinical trial programmes. Wegovy's STEP trials, including the landmark study by Wilding et al. published in the New England Journal of Medicine (2021), showed that patients taking semaglutide alongside diet and exercise experienced significant weight management benefits compared to placebo groups. The STEP 1 trial reported average weight loss of approximately 15% at 68 weeks, while STEP 5 demonstrated sustained results of 15.2% at two years.
Mounjaro's clinical evidence comes from the SURMOUNT trial programme, which evaluated tirzepatide's dual GIP and GLP-1 receptor agonist mechanism across the same dose escalation schedule. Both medications require the same careful dose progression from 0.25mg through to 2.4mg maintenance, ensuring optimal tolerability while maximising therapeutic benefits. Individual results may vary, and both treatments are prescription-only medicines requiring ongoing medical supervision throughout the dose escalation period.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of a natural hormone called glucagon-like peptide-1. This hormone is normally released by your intestines after eating and signals to your brain that you're becoming full. By activating GLP-1 receptors, Wegovy may help reduce appetite and increase feelings of satiety after smaller meals. The medication also slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged feelings of fullness. These mechanisms work together to support weight management when combined with a reduced-calorie diet and increased physical activity, though the escalating Mounjaro and Wegovy doses require careful medical monitoring to optimise effectiveness while minimising potential side effects.
Streamlined Ordering Process for All Mounjaro and Wegovy Doses
Accessing the complete range of Mounjaro and Wegovy doses through EverydayMeds follows our simplified three-step process designed for busy lifestyles. Begin with our three-minute online clinical assessment, which captures your medical history, current medications, and weight management goals to help determine the most appropriate treatment option. Your assessment then undergoes review by our qualified prescribers - standard review takes three working days, though express 24-hour review is available for urgent requirements. Once approved, your chosen dose ships via next-day delivery using our specialised cold-chain logistics network, maintaining the crucial 2-8°C temperature requirements throughout transit. This streamlined process ensures you can access any strength in the Mounjaro and Wegovy dose ranges without unnecessary delays, supporting consistent treatment adherence from week one through to maintenance therapy.
Storage and Practical Considerations for Mounjaro and Wegovy Doses
Proper storage of Mounjaro and Wegovy doses is essential for maintaining medication effectiveness throughout your treatment journey. Both medications require refrigeration at 2-8°C before first use, though Wegovy offers superior travel flexibility with up to 6 weeks at room temperature (below 30°C) once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. Both medications use similar pre-filled injection pen systems - Wegovy utilises Novo Nordisk's FlexTouch pen technology, while Mounjaro employs Eli Lilly's KwikPen system. The dose escalation schedule is identical for both medications: 0.25mg for weeks 1-4, 0.5mg for weeks 5-8, 1mg for weeks 9-12, 1.7mg for weeks 13-16, and 2.4mg from week 17 onwards, with each injection administered once weekly on the same day. This systematic progression cannot be accelerated, making reliable supply of each dose strength absolutely critical for treatment success.
Comparing Mounjaro and Wegovy Doses: Dual vs Single Pathway
The fundamental difference between Mounjaro and Wegovy doses lies in their receptor targeting mechanisms, despite following identical escalation schedules. Mounjaro's tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors, creating a dual-pathway approach to appetite regulation and glucose homeostasis. This dual mechanism may offer different therapeutic benefits compared to Wegovy's semaglutide, which specifically targets GLP-1 receptors only.
Both Mounjaro and Wegovy doses are subject to MHRA additional monitoring, indicated by the Black Triangle (▼) symbol, as both medications are relatively recent additions to UK weight management protocols. Storage requirements differ slightly, with Wegovy's extended room temperature stability potentially offering practical advantages for frequent travellers. However, both medications follow the same dose escalation timeline and require the same level of medical supervision throughout treatment. Both Wegovy and Mounjaro are available from EverydayMeds - your prescriber can help determine which mechanism aligns best with your individual treatment needs.
Your Complete Dose Solution: Order Today
EverydayMeds eliminates the uncertainty around Mounjaro and Wegovy doses by maintaining comprehensive stock levels across all strengths, ensuring your treatment never faces supply interruptions. New customers can begin their weight management journey using discount code FIRST40, while existing patients benefit from DOSE25 for subsequent orders - both codes are applied at checkout to reach our published prices. Our GPhC-registered pharmacy (#9012878) operates under strict UK regulatory standards, providing the quality assurance and clinical oversight essential for prescription-only medicines like Wegovy and Mounjaro. Visit https://everydaymeds.co.uk/collections/wegovy to complete your clinical assessment and take the first step towards medically-supervised weight management. Remember that both medications are designed to work alongside a reduced-calorie diet and increased physical activity, with ongoing prescriber support available throughout your dose escalation journey from 0.25mg through to 2.4mg maintenance therapy.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
